Neuropathy Pain Treatment Market by Type and Geography - Forecast and Analysis 2020-2024

  • Published: May 2020
  • Pages: 120
  • SKU: IRTNTR43322
Technavio

The 2021-2025 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The neuropathy pain treatment market size has the potential to grow by $1.70 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth.

This report provides a detailed analysis of the market by type (diabetic neuropathy, chemotherapy-induced neuropathy pain, postherpetic neuralgia, and others) and geography (APAC, Europe, MEA, North America, and South America). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Abbott Laboratories, Assertio Therapeutics Inc., AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., and Sanofi.

What will be the Neuropathy Pain Treatment Market Size in 2020?

Browse TOC and LoE with selected illustrations and example pages of Neuropathy Pain Treatment Market

Request a FREE sample now!

Who are the Major Neuropathy Pain Treatment Vendors?

The market is fragmented. Abbott Laboratories, Assertio Therapeutics Inc., AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., and Sanofi are some of the major market participants. Factors such as the presence of a large patient pool, growing focus on the development of drugs for the treatment of diabetic neuropathy pain, and focus toward the development of novel therapeutics for postherpetic neuralgia will offer immense growth opportunities. However, patent expiries hamper the growth prospects, growing preference for alternatives, and high unmet needs in the treatment of neuropathic pain affects the adoption rates may impede market growth. To make the most of the opportunities, vendors should focus on growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this neuropathy pain treatment market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this neuropathy pain treatment market analysis report provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

  • Abbott Laboratories
  • Assertio Therapeutics Inc. 
  • AstraZeneca Plc
  • Baxter International Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi

Which are the Key Markets for Neuropathy Pain Treatment?

For more insights on the market share of various regions Request for a FREE sample now!

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. North America will offer several growth opportunities to market vendors during the forecast period.

33% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for neuropathy pain treatment in North America. This report provides an accurate prediction of the contribution of all segments to the growth of the neuropathy pain treatment market size.

What are the Key Factors Covered in this Neuropathy Pain Treatment Market Report?

  • CAGR of the market during the forecast period 2020-2024
  • Detailed information on factors that will drive neuropathy pain treatment market growth during the next five years
  • Precise estimation of the neuropathy pain treatment market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the neuropathy pain treatment industry across North America, Europe, APAC, South America, and MEA
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of neuropathy pain treatment market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The neuropathy pain treatment market growth will increase by $1702.89 million during 2019-2024.
The neuropathy pain treatment market is expected to grow at a CAGR of 4.98% during 2019-2024.
Technavio has segmented the neuropathy pain treatment market by other1 (Diabetic neuropathy, Chemotherapy-induced neuropathy pain, Postherpetic neuralgia, and Others) and geographic (North America, Europe, APAC, South America, and MEA).
Abbott Laboratories, Assertio Therapeutics Inc. , AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., Sanofi are a few of the key vendors in the neuropathy pain treatment market.
North America will register the highest growth rate of 33.37% among the other regions. Therefore, the neuropathy pain treatment market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the neuropathy pain treatment market growth are:
  • Presence of large patient pool
The neuropathy pain treatment market vendors should focus on grabbing business opportunities from the diabetic neuropathy segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase

Technavio's SUBSCRIPTION platform

Register for a free trial today and gain instant access to 17,000+ market research reports.

START YOUR FREE TRIAL

Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>